Archives for September 28, 2018

Daily Archives: September 28, 2018


Swiss-based biotechnology firm, Therachon, has closed $60 million round of funding, which will advance its achondroplasia program toward a drug trial, with treatments expected sometime in 2019. Novo Holdings led a cast of existing and new investors in ...
Comments Off on Therachon’s Rare Genetic Diseases Program Gets $60 Million Boost